Recommendations for essential medicines for multiple sclerosis in low-resource settings.

Saved in:
Bibliographic Details
Title: Recommendations for essential medicines for multiple sclerosis in low-resource settings.
Authors: Saylor D; Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA; Department of Medicine, University Teaching Hospital, Lusaka, Zambia., Rijke N; Multiple Sclerosis International Federation, London, UK., McDonell J; MS Canada, Toronto, ON, Canada., Laurson-Doube J; Multiple Sclerosis International Federation, London, UK., Avasarala J; Department of Neurology, University of Kentucky Medical Center, Lexington, KY, USA., Baldin E; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy., Banerjee TK; National Neurosciences Centre Calcutta, Kolkata, India., Bogdanovic I; MS Platform Serbia, Belgrade, Serbia., Bove R; UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA., Chawla DK; East West Medical Center, New Delhi, India., Costello K; Can Do Multiple Sclerosis, Avon, CO, USA., Del Giovane C; Department of Medical and Surgical Sciences, University Hospital of Modena and Reggio Emilia, Modena, Italy; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland., Abkari NE; HANA Multiple Sclerosis Patients Association, Fes, Morocco., Filippini G; IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Foschi M; Department of Neuroscience, Multiple Sclerosis Center-Neurology Unit, S. Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Gonzalez-Lorenzo M; Laboratorio di Metodologia delle revisioni sistematiche e produzione di Linee Guida, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy., Helme A; Multiple Sclerosis International Federation, London, UK., Jacobs D; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kalincik T; Neuroimmunology Centre, Department of Neurology, The Royal Melbourne Hospital, Melbourne, Australia; CORe (Clinical Outcomes Research unit), Department of Medicine, University of Melbourne, Melbourne, Australia., Mantel-Teeuwisse A; Utrecht Centre for Pharmaceutical Policy and Regulation, Utrecht University, Utrecht, the Netherlands; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Minozzi S; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy., Navas C; Department of Neurology, Hospital San Jose, Clinica Universitaria Colombia, Bogota, Colombia., Nonino F; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy., Ojo OO; Neurology Unit, Department of Medicine, College of Medicine, Lagos Teaching Hospital, University of Lagos, Lagos, Nigeria., Ozcan B; Multiple Sclerosis Namibia, Windhoek, Namibia., Pasi E; WHO Collaborating Centre in Evidence-Based Research Synthesis and Guideline Development, Bologna, Italy., Peryer G; School of Health Sciences, University of East Anglia, Norwich, UK., Prato Chichiraldi A; Department of Psychology, Ministerio de Desarrollo Social de Uruguay, Montevideo, Uruguay., Ridley B; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy., Sokhi DS; Department of Neurology, Medical College, The Aga Khan University, Nairobi, Kenya., Traboulsee A; Department of Neurology, The University of British Columbia, Vancouver, BC, Canada., Tramacere I; IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Tye JS; National Neuroscience Institute, Singapore, Singapore., Vecchi S; Department of Epidemiology, Lazio Regional Health Service, Rome, Italy., Viswanathan S; Department of Neurology, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia., Xie F; Department of Health Research Methods, Evidence and Impact, Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON, Canada., Zeineddine M; Inserm U1094, IRD U270, University Limoges, Limoges, France; Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France., Schunemann H; Clinical Epidemiology and Research Center, Humanitas Research Hospital, Humanitas University, Milan, Italy., Piggott T; Department of Family Medicine, Queen's University, Kingston, ON, Canada; Peterborough Public Health, Peterborough, ON, Canada.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Apr; Vol. 31 (4), pp. 464-473. Date of Electronic Publication: 2024 Dec 31.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1477-0970
DOI:10.1177/13524585241308134